Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet PETINIMID 50mg / ml syrup
- Product code:
- W03052001
- Quantity:
- 1
- Indicated for:
- epilepsy
- Route of administration:
- oral
- Substance:
- ethosuximide (antiepileptic)
- ATC
- N03AD01 — Nervous system | Antiepileptics | Antiepileptics | Succinimide derivatives
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Suicidal ideation / mental changes
Seek medical help if suicidal thoughts or major behavior changes occur.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Ethosuximide is an anticonvulsant medication mainly used for the treatment of absence seizures in children and adults. It works by reducing abnormal electrical activity in the brain, helping to prevent absence seizures.
Ethosuximide is administered orally as capsules or syrup, according to the neurologist's instructions. The dose is adjusted individually, depending on the patient's response to treatment and any side effects.
Side effects may include nausea, vomiting, headaches, drowsiness, or, rarely, allergic reactions and liver or blood disorders. Medical monitoring is necessary throughout the treatment.
Ethosuximide is an effective option for controlling absence seizures, but its use requires careful medical supervision to manage possible side effects and ensure treatment effectiveness.
Ethosuximide is administered orally as capsules or syrup, according to the neurologist's instructions. The dose is adjusted individually, depending on the patient's response to treatment and any side effects.
Side effects may include nausea, vomiting, headaches, drowsiness, or, rarely, allergic reactions and liver or blood disorders. Medical monitoring is necessary throughout the treatment.
Ethosuximide is an effective option for controlling absence seizures, but its use requires careful medical supervision to manage possible side effects and ensure treatment effectiveness.
General data about PETINIMID 50mg / ml
- Substance:
- ethosuximide
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W03052001
- Concentration:
- 50mg / ml
- Pharmaceutical form:
- syrup
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for ethosuximide
Concentrations available for ethosuximide
- 250mg
- 50mg/ml